Contract award · 11 Feb 2026

NP90425 Faricimab (Vabysmo®)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded “Faricimab (Vabysmo®)” to Roche Products Ltd for £48.4m.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£48,357,375
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date11 Feb 2026
  2. Published11 Feb 2026Published the same day

Description

The Framework Agreement is for the supply of Faricimab (Vabysmo®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
25 Feb 2026 Roche Products Ltd £48.4m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

All contracts

More won by Roche Products Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview